A CLINICAL EXPERIENCE OF RIFAMPICIN SUPPOSITORY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS

PURPOSE: The usefulness of a rifampicin (RFP) suppository for treatment of pulmonary tuberculosis was examined in patients who had difficulty with oral consumption of medication.

SUBJECTS AND METHODS: Among inpatients receiving first-time treatment for pulmonary tuberculosis susceptible to both isoniazid (INH) and RFP, and who underwent standard 3- or 4-drug treatments including INH and RFP, we compared the number of days required for obtaining two and three consecutive negative sputum smears and cultures, respectively, in patients who received hospital-made suppositories or standard oral RFP administration.

RESULTS: There was no significant difference between groups in the number of days required for negative cultures and smears; although the times were equivalent, there were more number of elderly patients and those in generally poor condition in the RFP suppository group than the oral intake group.

CONCLUSION: RFP suppositories may be one method for administration of standard tuberculosis treatment in patients with difficulty in oral consumption of medication.

Medienart:

Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:90

Enthalten in:

Kekkaku : [Tuberculosis - 90(2015), 6 vom: 26. Juni, Seite 543-7

Sprache:

Japanisch

Beteiligte Personen:

Tsubota, Noriyuki [VerfasserIn]
Tanimukai, Shigeatsu [VerfasserIn]

Themen:

Antibiotics, Antitubercular
Comparative Study
English Abstract
Journal Article
Rifampin
Suppositories
VJT6J7R4TR

Anmerkungen:

Date Completed 15.12.2015

Date Revised 22.10.2015

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM253897548